A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors
Abstract
Keywords
Cancer; Molecular biology; Oncology
Bibliographic citation
Poveda A, Oaknin A, Romero I, Guerrero-Zotano A, Fariñas-Madrid L, Rodriguez-Freixinos V, et al. A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors. Sci Rep. 2021 Dec 24;11:4433.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/5965This item appears in following collections
- HVH - Articles científics [2958]
- VHIO - Articles científics [861]
The following license files are associated with this item: